Tevogen Bio Holdings (TVGN) EPS (Weighted Average and Diluted) (2022 - 2026)
Tevogen Bio Holdings (TVGN) reported EPS (Weighted Average and Diluted) of -$1.61 for Q1 2026, up 50.46% on a YoY basis from -$1.07 in Q1 2025, and up 79.77% quarter-over-quarter from -$7.96 in Q4 2025.
Tevogen Bio Holdings (TVGN) EPS (Weighted Average and Diluted) (2022 - 2026) Analysis & Trends
Tevogen Bio Holdings has reported EPS (Weighted Average and Diluted) for 5 years, with the latest figure at -$1.61 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 50.46% year-over-year to -$1.61; the trailing twelve-month figure through Mar 2026 stood at -$9.63 (down 41.41% YoY), and the FY2025 full-year result was -$8.08, down 130.86% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$1.61, up from -$7.96 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.05 in Q4 2022, with the low at -$7.96 in Q4 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$1.01 across 5 years, with a median of -$0.04 in 2024.
- Annual changes were most pronounced in 2023 — EPS (Weighted Average and Diluted) plunged 47855.47% — and 2024, when it jumped 77.78%.
- Tevogen Bio Holdings' EPS (Weighted Average and Diluted) stood at $0.05 in 2022, then tumbled by 380.0% to -$0.14 in 2023, then plunged by 2392.86% to -$3.49 in 2024, then slumped by 128.08% to -$7.96 in 2025, then soared by 79.77% to -$1.61 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$1.61 (Q1 2026), -$7.96 (Q4 2025), and -$0.03 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 0.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -0.61 |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - | -1.61 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.61 |
| Dec 31, 2025 | -7.96 |
| Sep 30, 2025 | -0.03 |
| Jun 30, 2025 | -0.03 |
| Mar 31, 2025 | -3.25 |
| Dec 31, 2024 | -3.49 |
| Sep 30, 2024 | -0.03 |
| Jun 30, 2024 | -0.04 |
| Mar 31, 2024 | -0.26 |
| Dec 31, 2023 | -0.14 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.18 |
| Mar 31, 2023 | -0.26 |
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.00 |